Author:
Neira-Peña T.,Espina-Marchant P.,Rojas-Mancilla E.,Esmar D.,Kraus C.,Munoz V.,Perez R.,Rivera B.,Bustamante D.,Valdes J. L.,Hermoso M.,Gebicke-Haerter P.,Morales P.,Herrera-Marschitz M.
Reference104 articles.
1. Abdelkarim, G. E., Gertz, K., Harms, C., Katchanov, J., Dimagl, U., Szabo, C., & Endres, M. (2001). Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. International Journal of Molecular Medicine, 7, 255–260.
2. Akil, M., Edgar, C. L., Pierri, J. N., Casali, S., & Lewis, D. A. (2000). Decreased density of tyrosine hydroxylase-immunoreactive axons in the entorhinal cortex of schizophrenic subjects. Biological Psychiatry, 47, 361–370.
3. Alano, C. C., Kauppinen, T. M., Valls, A. V., & Swanson, R. A. (2006). Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proceedings of the National Academy Sciences USA, 103, 9685–9690.
4. Allende-Castro, C., Espina-Marchant, P., Bustamante, D., Rojas-Mancilla, E., Neira, T., Gutierrez-Hernandez, M. A., Esmar, D., Valdes, J. L., Morales, P., Gebicke-Haerter, P. J., & Herrera-Marschitz, M. (2012). Further studies on the hypothesis of PARP-1 inhibition as a strategy for lessening the long-term effects produced by perinatal asphyxia: Effects of nicotinamide and theophylline on PARP-1 activity in brain and peripheral tissue. Neurotoxicity Research, 22, 79–90.
5. Amé, J.-C., Spenlehauer, C., & de Murcia, G. (2004). The PARP superfamily. BioEssays, 26, 882–893.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献